Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > antihypertensive drugs market
Get a free sample of Antihypertensive Drugs Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Antihypertensive Drugs Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Key trends in the market are focused on innovations that aims to enhance treatment efficacy, improve patient adherence, and reduce healthcare costs.
Key players in the market include AbbVie, AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Johnson & Johnson Services, Lupin, Merck & Co, Noden Pharma DAC, Novartis AG, Pfizer, and Sanofi.
The U.S. led the North American antihypertensive drugs market in 2024, generating approximately USD 9 billion, attributed to the high prevalence of hypertension in the region.
The diuretics segment held a 22.4% market share in 2024, primarily due to the significant adoption of thiazide diuretics for their proven efficacy in lowering blood pressure.
The global antihypertensive drugs industry was valued at USD 23.9 billion in 2024 and is projected to grow at a 4.1% CAGR from 2025 to 2034, driven by the rising prevalence of hypertension and advancements in drug formulations.